Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” [Gynecol. Oncol. 154 (2019) 441–448] (Gynecologic Oncology (2019) 154(2) (441–448), (S0090825819311813), (10.1016/j.ygyno.2019.04.679))

The Authors acknowledge the original list of individuals in The HGSC CRS Collaborative Network outlined in Appendix A. Supplementary Data was incomplete. The complete list is outlined below, with the previously omitted names bolded. The authors would like to apologise for any inconvenience caused. Simi Aggarwal (Tata Medical Center, Kolkata, India), Holger Bronger (Technische Universität München, Germany), Elizabeth B Brown (Royal Devon and Exeter NHS Foundation Trust, Devon, United Kingdom), Martin Buck (Bendat Family Comprehensive Cancer Centre, St John of God Subiaco Hospital, Subiaco, Australia), Syed A. Bukhari (Birmingham Women's Hospital, United Kingdom), Edwina Coghlan (University of Notre Dame Australia, Fremantle, Australia), Nichola Cope (Royal Devon and Exeter NHS Foundation Trust, Devon, United Kingdom), Michelle Samora de Almeida (Federal University of São Paulo, São Paulo, Brazil), Cornelius D. De Kroon (Leiden University Medical Center, Leiden, The Netherlands), Andrew Dean (Bendat Family Comprehensive Cancer Centre, St John of God Subiaco Hospital, Subiaco, Australia), Michael-John Devlin (Barts Health NHS Trust, United Kingdom), Helena M. Ditzel (University of Southern Denmark, Odense, Denmark), Enken Drecoll (Technische Universität München, Munich, Germany), Takahiro Ebata (National Cancer Center Hospital, Tokyo, Japan) Anna Fagotti (Fondazione Policlinico Gemelli. Università Cattolica del Sacro Cuore), Asma Faruqi (Bart's Health NHS Trust, United Kingdom), Laura Feeney (Northern Ireland Cancer Centre, Belfast, United Kingdom), Kavita Gupta (Tata Medical Center, Kolkata, India), Ian Harley (Belfast Health and Social Care Trust, Belfast, United Kingdom), Frediano Inzani (Fondazione Policlinico Gemelli. Università Cattolica del Sacro Cuore), Arjun R. Jeyarajah (Department of Gynaecological Oncology, United Kingdom), MH Eleanor Koay (King Edward Memorial Hospital, Subiaco, Australia), Judith R. Kroep (Leiden University Medical Center, Leiden, The Netherlands), Jung-Yun Lee (Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea), Yee Leung (Division of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, University of Western Australia, Crawley, Australia), Michelle Lockley (Queen Mary University of London, United Kingdom), Alice R Loft (Canterbury District Health Board, Christchurch, New Zealand), Daniel MaGee (University of Notre Dame, Fremantle, Australia), Ranjit Manchanda (Barts Health NHS Trust), Sarah McKenna (Belfast City Hospital, Belfast, United Kingdom), Divya Midha (Tata Medical Center, Kolkata, India), David Millan (Queen Elizabeth University Hospital Glasgow, Glasgow, United Kingdom), Joanne Millar (Belfast City Hospital, Belfast, United Kingdom), Rowan Miller (Barts Health NHS Trust), Ganendra R. Mohan (Bendat Family Comprehensive Cancer Centre, St John of God Subiaco Hospital, Subiaco, Australia), Sohail Mughal (Belfast City Hospital, Belfast, United Kingdom), Sergio Mancini Nicolau (Federal University of São Paulo, São Paulo, Brazil), James Nevin (Birmingham Women's Hospital, United Kingdom), Abigail S. Oakley (Queen Elizabeth University Hospital Glasgow, Glasgow, United Kingdom), Mary Quigley (Queen's Hospital, United Kingdom), Bhavana Rai (Postgraduate Institute of Medical Education and Research, Chandigarh, India), Arvind Rajwanshi (Postgraduate Institute of Medical Education and Research, Chandigarh, India), Stuart G. Salfinger (Bendat Family Comprehensive Cancer Centre, St John of God Subiaco Hospital, Subiaco, Australia), Giovanni Scambia (Fondazione Policlinico Gemelli. Università Cattolica del Sacro Cuore, Roma, Italy), Kate Scatchard (Royal Devon and Exeter NHS Foundation Trust, Devon, United Kingdom), Barbara Schmalfeldt (Technische Universität München, Munich, Germany), Bryony Simcock (Christchurch Women's Hospital, Christchurch, New Zealand), Priya Singh (Postgraduate Institute of Medical Education and Research, Chandigarh, India), Kyle C. Strickland (Duke University Medical Center, Durham, United State of America), Vainta Suri (Postgraduate Institute of Medical Education and Research, Chandigarh, India), Sheeba Syed (Queen Elizabeth University Hospital Glasgow, Glasgow, United Kingdom), Peter Sykes (University of Otago, Christchurch, New Zealand), Adeline Tan (Western Women's' Pathology, Western Diagnostic Pathology, Wembley, Australia), Jason Tan (WOMEN Centre, West Leederville, Australia), Kenji Tamura (National Cancer Center Hospital, Tokyo, Japan), Emily Thompson (University of British Columbia, Vancouver, Canada), Anna V. Tinker (Vancouver General Hospital, Vancouver, Canada), Giorgia Trevisan (Barts Health NHS Trust, United Kingdom), Maria Gabriela Baumgarten Kuster Uyeda (Federal University of São Paulo, São Paulo, Brazil), Michelle M. Vaughan (Canterbury District Health Board, Canterbury, New Zealand), Wilko Weichert (Technische Universität München, Germany), Anthony Williams (Birmingham Women's Hospital, United Kingdom), Sarah Williams (Birmingham Women's Hospital, United Kingdom), Hiroshi Yoshida (National Cancer Center Hospital, Tokyo, Japan) Pier Carlo Zorzato (Fondazione Policlinico Gemelli. Università Cattolica del Sacro Cuore, Roma, Italy).